Feature | April 27, 2012

Cardiovascular Nuclear Imaging Advances Highlighted at SNM Symposium

April 27, 2012 — More than 150 molecular imaging professionals gathered last week at the Society of Nuclear Medicine’s third Multimodality Cardiovascular Molecular Imaging Symposium held at the National Institutes of Health. The two and a half day symposium brought together individuals from multiple scientific disciplines — including chemistry, engineering, physics, molecular biology, cardiovascular physiology and imaging sciences — with the goal of promoting the emerging field of cardiovascular molecular imaging.

“Our program this year focused on advances in targeted imaging of the cardiovascular system including imaging of cardiovascular receptors, stem cell therapy, vascular biology, myocardial metabolism and other relevant biological processes,” said Albert J. Sinusas, M.D., program chair of the symposium. “The symposium proved to be very successful, stimulating further interest in the field and advancing the promotion of basic science research and the development of clinical applications in cardiovascular molecular imaging.”

The first day of the symposium highlighted the development and application of novel imaging probes for evaluation and treatment of cardiovascular disease, along with novel hybrid imaging technology. The imaging technologies reviewed included; fluorescence imaging, chemical exchange saturation contrast imaging, optoacoustic imaging, multispectral CT as well as microSPECT and microPET imaging. Professor Jason S. Lewis, Ph.D., vice chair of radiology and chief attending of the radiochemistry and imaging sciences service in the Department of Radiology at Memorial Hospital for Cancer and Allied Diseases, in New York City, presented a keynote address on molecular imaging agents that are currently in translation for imaging cancer.

Lewis noted, “Now is a particularly interesting time for the field of cardiology. We have multiple new agents coming down the pipeline in the oncology world that can be used in various imaging capacities; there are hopefully a lot of interesting parallels and lessons to be learnt in the nuclear cardiology field based on our experience with cancer. Having these new targeted imaging options allows us to personalize medicine to make sure that the patient is getting the most appropriate test for their indication.”

Attendees switched their focus to specific diseases on day two of the symposium and learned about imaging of atherosclerosis and vascular remodeling, imaging angiogenesis and arteriogenesis, metabolic imaging of the heart, imaging of myocardial injury, repair and remodeling. Ira Tabas, M.D., Ph.D., provided another keynote lecture on the pathophysiology of atherosclerosis, and the associated implications for targeted imaging of the vasculature. The symposium concluded with sessions on stem cell therapy and challenges of translation of molecular imaging and therapy, with a third keynote lecture by Lee Josephson, Ph.D.

In addition to scientific program, a total of 22 abstracts representing the most novel ideas in molecular imaging research as applied to the cardiovascular system, were accepted for the symposium’s poster session. The winning abstract for the symposium was “Quantitative first-pass perfusion MRI of the mouse heart: data acquisition, reconstruction, and analysis strategies,” authored by N.K. Naresh. The first runner-up was “Therapeutic efficacy of different liposomal glucocorticoids as a treatment for atherosclerosis assessed by multimodal imaging,” authored by M.E. Lobatto.

For more information: www.snm.org/cmiit

 

Related Content

Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are major causes of...
PET imaging, atherosclerotic plaque, inflammation, Ga-68-pentixafor, Technishe Universitat Munchen, Germany

Note the high uptake of Ga-68-pentixafor on multi-planar reconstructions in the organs expressing CXCR4 such as the spleen (red arrows) and adrenal glands (yellow arrows), which was nearly completely blocked by the pre-injection of AMD 3100, a potent CXCR4 inhibitor. Strong accumulation of Ga-68-pentixafor was also found in the kidneys (asterisks) reflecting the renal clearance of the tracer. In addition, high, focal activities were detected in the abdominal aorta (red arrowheads) and right carotid artery (orange arrowheads) of atherosclerotic rabbits, whereas no significant signal could be detected in the non-injured left carotid artery (white arrowheads) of atherosclerotic and control rabbits, as well as in the abdominal aorta and right carotid artery of control rabbits. Furthermore, focal activities detected with PET in atherosclerotic plaques of the abdominal aorta and the right carotid artery decreased significantly when the same rabbit was re-imaged after blocking CXCR4 receptors. Image courtesy of Fabien Hyafil, M.D., Ph.D., Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

News | PET Imaging | March 03, 2017
In the featured article of the March 2017 issue of The Journal of Nuclear Medicine, researchers demonstrate that a new...
ASNC, SNMMI, position statement, myocardial perfusion PET, coronary artery disease
News | PET Imaging | September 01, 2016
September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of...
cardiac PET, myocardial perfusion, PET-CT, cardiac perfusion

A PET-CT cardiac perfusion exam from a Siemens Biograph scanner. The black and white areas of the image show the CT imaging of the anatomy. The colored portion shows the PET overlay on the myocardium and is color-coded to show tracer uptake values. This can show areas of the heart muscle where there are perfusion defects cause by infarcts or coronary artery blockages due to a heart attack and help determine the severity of the ischemia.

Feature | PET Imaging | June 03, 2016 | Dave Fornell
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enabl
blood clot detection, single scan, rats, radionuclides, Peter Caravan, whole body

The whole body of a rat can be imaged for blood clots with one PET scan (which is overlaid here on an MRI image) using the FBP8 probe. Arrow points to a blood clot. Image courtesy of Peter Caravan, Ph.D.

News | PET Imaging | September 23, 2015
September 23, 2015 — New research de
Overlay Init